Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Jachetti

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Epigenomics|March 26, 2024
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell responseIrene Fischetti, Laura Botti, Roberta Sulsenti, et al.
Journal of Leukocyte Biology|March 1, 2019
Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activityElena Jachetti, Federica D'Incà, Luca Danelli, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Cancer Research|November 1, 2022
ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer TransformationMilena Perrone, Claudia Chiodoni, Mara Lecchi, et al.
Frontiers in Immunology|March 19, 2021
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to AdenocarcinomaRoberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, et al.
Expert Review of Anticancer Therapy|February 21, 2023
Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvementRiccardo Ray Colciago, Irene Fischetti, Carlotta Giandini, et al.
Cancer Research|March 27, 2015
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell ActivationElena Jachetti, Sara Caputo, Stefania Mazzoleni, et al.
Cancer Research|March 18, 2020
Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal PhenotypeMaria Teresa Majorini, Valeria Cancila, Alice Rigoni, et al.
Frontiers in Immunology|June 4, 2021
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress ConditionsBarbara Bassani, Claudio Tripodo, Paola Portararo, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Epigenomics|March 26, 2024
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell responseIrene Fischetti, Laura Botti, Roberta Sulsenti, et al.
Journal of Leukocyte Biology|March 1, 2019
Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activityElena Jachetti, Federica D'Incà, Luca Danelli, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Cancer Research|November 1, 2022
ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer TransformationMilena Perrone, Claudia Chiodoni, Mara Lecchi, et al.
Frontiers in Immunology|March 19, 2021
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to AdenocarcinomaRoberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, et al.
Expert Review of Anticancer Therapy|February 21, 2023
Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvementRiccardo Ray Colciago, Irene Fischetti, Carlotta Giandini, et al.
Cancer Research|March 27, 2015
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell ActivationElena Jachetti, Sara Caputo, Stefania Mazzoleni, et al.
Cancer Research|March 18, 2020
Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal PhenotypeMaria Teresa Majorini, Valeria Cancila, Alice Rigoni, et al.
Frontiers in Immunology|June 4, 2021
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress ConditionsBarbara Bassani, Claudio Tripodo, Paola Portararo, et al.
Pageof 5